These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 34731508)

  • 21. Emerging Multidrug-Resistant Candida duobushaemulonii Infections in Panama Hospitals: Importance of Laboratory Surveillance and Accurate Identification.
    Ramos R; Caceres DH; Perez M; Garcia N; Castillo W; Santiago E; Borace J; Lockhart SR; Berkow EL; Hayer L; Espinosa-Bode A; Moreno J; Jackson BR; Moran J; Chiller T; de Villarreal G; Sosa N; ; Vallabhaneni S
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29695521
    [No Abstract]   [Full Text] [Related]  

  • 22. Laboratory Analysis of an Outbreak of Candida auris in New York from 2016 to 2018: Impact and Lessons Learned.
    Zhu Y; O'Brien B; Leach L; Clarke A; Bates M; Adams E; Ostrowsky B; Quinn M; Dufort E; Southwick K; Erazo R; Haley VB; Bucher C; Chaturvedi V; Limberger RJ; Blog D; Lutterloh E; Chaturvedi S
    J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 31852764
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of readily available laboratory tests for the identification of the emerging yeast Candida auris in Mexico.
    González-Durán E; Contreras-Pérez CU; Caceres DH; Ríos-Rosas C; Piñón-Ortega JJ; Téllez-Saucedo MD; Marín-Suro ES; Wong-Arámbula CE; Moreno-Escobar EA; Ramírez-González JE; Ramírez-Barrios JG; Montes-Colima NA; Lockhart SR; Martínez-Montiel N; Martínez-Contreras RD; García-Ruíz P; Salazar-Sánchez MI; Hernández-Rivas L; López-Martínez I
    Arch Microbiol; 2022 Sep; 204(9):592. PubMed ID: 36053373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical, microbiological, and genomic characteristics of clade-III
    de St Maurice A; Parti U; Anikst VE; Harper T; Mirasol R; Dayo AJ; Garner OB; Prabaker KK; Yang S
    Infect Control Hosp Epidemiol; 2023 Jul; 44(7):1093-1101. PubMed ID: 36052507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis, management and prevention of Candida auris in hospitals: position statement of the Australasian Society for Infectious Diseases.
    Ong CW; Chen SC; Clark JE; Halliday CL; Kidd SE; Marriott DJ; Marshall CL; Morris AJ; Morrissey CO; Roy R; Slavin MA; Stewardson AJ; Worth LJ; Heath CH;
    Intern Med J; 2019 Oct; 49(10):1229-1243. PubMed ID: 31424595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Vitro activity of ravuconazole against Candida auris and vaginal candida isolates.
    Dong J; Liang G; Zheng H; Kan S; Song N; Zhang M; Liu W
    Mycoses; 2021 Jun; 64(6):651-655. PubMed ID: 33609301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Cluster of Neonatal Infections Caused by Candida auris at a Large Referral Center in Colombia.
    Alvarado-Socarras JL; Vargas-Soler JA; Franco-Paredes C; Villegas-Lamus KC; Rojas-Torres JP; Rodriguez-Morales AJ
    J Pediatric Infect Dis Soc; 2021 May; 10(5):549-555. PubMed ID: 33528008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in
    Rybak JM; Muñoz JF; Barker KS; Parker JE; Esquivel BD; Berkow EL; Lockhart SR; Gade L; Palmer GE; White TC; Kelly SL; Cuomo CA; Rogers PD
    mBio; 2020 May; 11(3):. PubMed ID: 32398311
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of Voriconazole, Isavuconazole, Fluconazole, and Anidulafungin in the Treatment of Emerging Candida auris Using an Immunocompromised Murine Model of Disseminated Candidiasis.
    Gamal A; Long L; Herrada J; Aram J; McCormick TS; Ghannoum MA
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0054921. PubMed ID: 34228541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
    Chowdhary A; Prakash A; Sharma C; Kordalewska M; Kumar A; Sarma S; Tarai B; Singh A; Upadhyaya G; Upadhyay S; Yadav P; Singh PK; Khillan V; Sachdeva N; Perlin DS; Meis JF
    J Antimicrob Chemother; 2018 Apr; 73(4):891-899. PubMed ID: 29325167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergency of fungemia cases caused by fluconazole-resistant Candida auris in Beijing, China.
    Chen Y; Zhao J; Han L; Qi L; Fan W; Liu J; Wang Z; Xia X; Chen J; Zhang L
    J Infect; 2018 Dec; 77(6):561-571. PubMed ID: 30219662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Candida auris: a global pathogen that has taken root in Colombia.
    Escandón P; Lockhart SR; Chow NA; Chiller TM
    Biomedica; 2023 Aug; 43(Sp. 1):278-287. PubMed ID: 37721898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus - United States, May 2013-August 2016.
    Vallabhaneni S; Kallen A; Tsay S; Chow N; Welsh R; Kerins J; Kemble SK; Pacilli M; Black SR; Landon E; Ridgway J; Palmore TN; Zelzany A; Adams EH; Quinn M; Chaturvedi S; Greenko J; Fernandez R; Southwick K; Furuya EY; Calfee DP; Hamula C; Patel G; Barrett P; ; Lafaro P; Berkow EL; Moulton-Meissner H; Noble-Wang J; Fagan RP; Jackson BR; Lockhart SR; Litvintseva AP; Chiller TM
    MMWR Morb Mortal Wkly Rep; 2016 Nov; 65(44):1234-1237. PubMed ID: 27832049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Head-to-head comparison of CLSI, EUCAST, Etest and VITEK®2 results for Candida auris susceptibility testing.
    Ceballos-Garzon A; Garcia-Effron G; Cordoba S; Rodriguez JY; Alvarez-Moreno C; Pape PL; Parra-Giraldo CM; Morales-López S
    Int J Antimicrob Agents; 2022 Apr; 59(4):106558. PubMed ID: 35227828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence of highly resistant
    Thomsen J; Abdulrazzaq NM; Oulhaj A; Nyasulu PS; Alatoom A; Denning DW; Al Dhaheri F; ; Menezes GA; Moubareck CA; Senok A; Everett DB
    Front Public Health; 2023; 11():1244358. PubMed ID: 38292390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [First isolation de Candida auris in Chile].
    Moreno MV; Simian ME; Villarroel J; Fuenzalida LM; Yarad MF; Soto A; Silva V; Pimentel X
    Rev Chilena Infectol; 2019 Dec; 36(6):767-773. PubMed ID: 33660757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characterisation and clinical outcomes of Candida auris infection: Single-centre experience in Saudi Arabia.
    Almaghrabi RS; Albalawi R; Mutabagani M; Atienza E; Aljumaah S; Gade L; Forsberg K; Litvintseva A; Althawadi S
    Mycoses; 2020 May; 63(5):452-460. PubMed ID: 32072717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterisation of Candida auris isolates from immunocompromised patients in a tertiary-care hospital in Kuwait reveals a novel mutation in FKS1 conferring reduced susceptibility to echinocandins.
    Asadzadeh M; Mokaddas E; Ahmad S; Abdullah AA; de Groot T; Meis JF; Shetty SA
    Mycoses; 2022 Mar; 65(3):331-343. PubMed ID: 34953089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rezafungin
    Helleberg M; Jørgensen KM; Hare RK; Datcu R; Chowdhary A; Arendrup MC
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Two-Component Response Regulator Ssk1 and the Mitogen-Activated Protein Kinase Hog1 Control Antifungal Drug Resistance and Cell Wall Architecture of Candida auris.
    Shivarathri R; Jenull S; Stoiber A; Chauhan M; Mazumdar R; Singh A; Nogueira F; Kuchler K; Chowdhary A; Chauhan N
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33055262
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.